Integra Lifesciences Holdings Corp (IART)
23.58
+0.58
(+2.52%)
USD |
NASDAQ |
Nov 22, 16:00
23.55
-0.03
(-0.13%)
Pre-Market: 20:00
Integra Lifesciences Holdings Cash from Investing (Quarterly): -10.40M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -10.40M |
| June 30, 2024 | -322.20M |
| March 31, 2024 | -53.96M |
| December 31, 2023 | -57.23M |
| September 30, 2023 | -7.697M |
| June 30, 2023 | -15.55M |
| March 31, 2023 | -13.70M |
| December 31, 2022 | -54.82M |
| September 30, 2022 | 14.80M |
| June 30, 2022 | -4.498M |
| March 31, 2022 | -14.07M |
| December 31, 2021 | -27.48M |
| September 30, 2021 | -8.475M |
| June 30, 2021 | -7.917M |
| March 31, 2021 | -117.57M |
| December 31, 2020 | -35.92M |
| September 30, 2020 | -6.718M |
| June 30, 2020 | -3.949M |
| March 31, 2020 | -21.48M |
| December 31, 2019 | -20.61M |
| September 30, 2019 | -108.84M |
| June 30, 2019 | -17.41M |
| March 31, 2019 | -15.81M |
| December 31, 2018 | -25.33M |
| September 30, 2018 | -16.34M |
| Date | Value |
|---|---|
| June 30, 2018 | 1.266M |
| March 31, 2018 | -9.298M |
| December 31, 2017 | -983.57M |
| September 30, 2017 | -7.107M |
| June 30, 2017 | -37.52M |
| March 31, 2017 | -193.14M |
| December 31, 2016 | -21.14M |
| September 30, 2016 | -6.707M |
| June 30, 2016 | -8.043M |
| March 31, 2016 | -6.73M |
| December 31, 2015 | -37.82M |
| September 30, 2015 | -315.45M |
| June 30, 2015 | -13.11M |
| March 31, 2015 | -5.632M |
| December 31, 2014 | -98.85M |
| September 30, 2014 | -8.775M |
| June 30, 2014 | -9.356M |
| March 31, 2014 | -246.34M |
| December 31, 2013 | -10.13M |
| September 30, 2013 | -13.39M |
| June 30, 2013 | -13.69M |
| March 31, 2013 | -13.09M |
| December 31, 2012 | -29.77M |
| September 30, 2012 | 19.86M |
| June 30, 2012 | -5.523M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-322.20M
Minimum
Jun 2024
14.80M
Maximum
Sep 2022
-39.47M
Average
-14.81M
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -1.427B |
| Haemonetics Corp | -23.37M |
| ResMed Inc | 2.146M |
| Globus Medical Inc | -14.97M |
| Perspective Therapeutics Inc | -29.74M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 22.48M |
| Cash from Financing (Quarterly) | -19.92M |
| Free Cash Flow | 38.04M |
| Free Cash Flow Per Share (Quarterly) | -0.0937 |
| Free Cash Flow to Equity (Quarterly) | 11.54M |
| Free Cash Flow to Firm (Quarterly) | 0.3626M |
| Free Cash Flow Yield | 2.08% |